Company News


April 28, 2021

MyoStrain®, MyoStress™ Rapid Hyperventilation Breath-hold Maneuver Enables First-of-its-Kind Needle-Free Stress Protocol for the Accurate Detection of Myocardial Ischemia

A new peer-reviewed study accepted in the Journal of the American College of Cardiology: Cardiovascular Imaging validated Myocardial Solutions (“MSI”) technologies MyoStrain and MyoStress in a new stress testing protocol utilizing a hyperventilation breath-hold (HVBH) maneuver to accurately ...

Read more >

May 13, 2021

MyoStrain® Provides Rapid, Accurate Assessment to Help Clinicians Detect Myocardial Ischemia and Rule Out Obstructive Coronary Artery Disease in Acute Chest Pain Patients

Myocardial Solutions (“MSI”) technologies MyoStrain® (fSENC) was featured in a newly published article exploring the effectiveness of cardiovascular magnetic resonance (CMR) and segmental strain to detect ischemia in patients suspected of obstructive coronary artery disease (CAD)...

Read more >

April 20, 2021

MyoStrain® Provides Quantitative Heart Failure Risk Assessment to Help Clinicians Individualize and Monitor Treatment in Asymptomatic Patients with Non-Ischemic Cardiomyopathy

A new article published in the Journal of Cardiovascular Magnetic Resonance utilized MyoStrain (fast-SENC) to accurately risk-stratify asymptomatic cardiac patients across multiple disease states. The article demonstrated MyoStrain’s clinical utility as a critical risk stratification tool to ...

Read more >

February 21, 2021

MyoStrain® and MyoStress™ Presented in Three New Abstracts at SCMR 2021

Myocardial Solutions, Inc. (“MSI”) attended the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th Annual Scientific Sessions, held virtually February 18-20, 2021. This year, SCMR main topics focused on new and traditional use cases of CMR, as well as exploring the use of CMR ...

Read more >

February 17, 2021

Abstract Posters and Presentations Featuring MyoStrain® at SCMR Virtual Scientific Sessions 2021

Myocardial Solutions,Inc. (“MSI”) will attend the Society for Cardiovascular Magnetic Resonance’s (“SCMR”) 24th annual scientific sessions virtually from February 18-21, 2021. The event focuses on highlighting breakthrough developments in new cardiovascular magnetic resonance (CMR) techniques ...

Read more >

February 11, 2021

MyoStrain® Provides Comprehensive Assessment of Myocardial Deformation to Help Physicians Risk-Stratify Heart Failure Patients for Individualized Cardiac Treatment

A new article published in the European Society of Cardiology (ESC) Heart Failure Journal demonstrated MyoStrain’s ability to accurately detect and delineate patterns of myocardial dysfunction between heart failure (HF) types and severity...

Read more >

January 25, 2021

JACC Cardiovascular Imaging Publishes New Peer-Reviewed Article Validating MyoStrain® for the Detection of Asymptomatic Cardiac Dysfunction and Ability to Risk-Stratify Patients for Individualized Care

A new pivotal research paper published in the Journal of American College of Cardiology (JACC) Cardiovascular Imaging presents several key validations for the clinical use of MyoStrain® in determining the risk of heart failure across multiple cardiac disease states.

Read more >
Philips healthcare presents MyoStrain at RSNA 2020

December 8, 2020

Presentation: Philips Healthcare Presents MyoStrain® at RSNA 2020

Philips Healthcare presented MyoStrain® at RSNA 2020 and discussed how MyoStrain's MRI-based cardiac diagnostic solutions may help transform cardiovascular care and enable physicians to quantify subtle changes in intra-myocardial heart function.

Read more >
MyoStrain Featured at VCOS 2020 Satellite Symposium

October 8, 2020

Myocardial Solutions Sponsors Featured MyoStrain® Satellite Symposium at 2020 Virtual Cardio-Oncology Summit (V-COS)

Myocardial Solutions (MSI) featured MyoStrain® in a satellite symposium at the first ever International Cardio-Oncology Summit 2020, a joint CardioTox and Global Cardio-Oncology Society (GCOS) initiative attracting oncologists, cardiologists, radiologists and pharmacists from around the world to ...

Read more >

September 24, 2020

Society for Cardiovascular Magnetic Resonance Lists Fast-SENC in New CMR-Protocols for Identifying Cardiac Damage in COVID-19 Patients

MyoStrain® was included in a new article published in the Journal of Cardiovascular Magnetic Resonance (JCMR) by the Society of Cardiovascular Magnetic Resonance (SCMR). The paper provides specific and detailed recommendations on the use of cardiovascular magnetic resonance (CMR) protocols for...

Read more >